Calidi Biotherapeutics, Inc. Liquidation Value
CLDI
Other
Cash & Equivalents
$11.84M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $11.84M
Total Obligations: -$6.50M
$5.34M
Per share: $0.74
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $11.84M
AR: $0
Total Obligations: -$6.50M
$5.34M
Per share: $0.74
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $11.84M
AR: $0
Inventory: $0
Total Obligations: -$6.50M
$5.34M
Per share: $0.74
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $5.34M | $0.74 |
| Liquid Liquidation Value | $5.34M | $0.74 |
| Operating Liquidation Value | $5.34M | $0.74 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $11.84M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $3.94M |
| Long-term Debt | $600,000 |
| Op. Lease Liability | $1.68M |
| Finance Lease | $282,000 |
| Shares Outstanding | 7.2M |
Explore all 152 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $11.84M | N/A | N/A | N/A | $3.94M | $600,000 | $1.68M | $282,000 |
| 2025-09-30 | $21.39M | N/A | N/A | N/A | $5.19M | $600,000 | $1.99M | $309,000 |
| 2025-06-30 | $10.86M | N/A | N/A | N/A | $5.35M | $600,000 | $2.30M | $339,000 |
| 2025-03-31 | $21.76M | N/A | N/A | N/A | $5.43M | $600,000 | $2.77M | $198,000 |
| 2024-12-31 | $9.60M | N/A | N/A | N/A | $9.50M | $600,000 | $3.05M | $211,000 |
| 2024-09-30 | $1.90M | N/A | N/A | N/A | $11.58M | $2.37M | $3.32M | $235,000 |
| 2024-09-27 | N/A | N/A | N/A | N/A | N/A | $200,000 | N/A | N/A |
| 2024-06-30 | $800,000 | N/A | N/A | N/A | $13.05M | $1.93M | $3.58M | $248,000 |
▼ Community Notes